DK0680346T3 - Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod - Google Patents

Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod

Info

Publication number
DK0680346T3
DK0680346T3 DK93904180T DK93904180T DK0680346T3 DK 0680346 T3 DK0680346 T3 DK 0680346T3 DK 93904180 T DK93904180 T DK 93904180T DK 93904180 T DK93904180 T DK 93904180T DK 0680346 T3 DK0680346 T3 DK 0680346T3
Authority
DK
Denmark
Prior art keywords
blood
nitric oxide
oxide concentration
increasing
increasing nitric
Prior art date
Application number
DK93904180T
Other languages
Danish (da)
English (en)
Inventor
Anthony E Bolton
Original Assignee
Vasogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasogen Inc filed Critical Vasogen Inc
Application granted granted Critical
Publication of DK0680346T3 publication Critical patent/DK0680346T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0216—Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
DK93904180T 1992-02-07 1993-02-08 Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod DK0680346T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83279892A 1992-02-07 1992-02-07
US94132692A 1992-09-04 1992-09-04
PCT/GB1993/000259 WO1993015779A1 (en) 1992-02-07 1993-02-08 Method of increasing the concentration of nitric oxide in blood

Publications (1)

Publication Number Publication Date
DK0680346T3 true DK0680346T3 (da) 2002-10-28

Family

ID=27125561

Family Applications (2)

Application Number Title Priority Date Filing Date
DK02014086T DK1243278T3 (da) 1992-02-07 1993-02-08 Anvendelse af blod, som har en foröget koncentration af nitrogenoxid, til fremstilling af et medikament
DK93904180T DK0680346T3 (da) 1992-02-07 1993-02-08 Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK02014086T DK1243278T3 (da) 1992-02-07 1993-02-08 Anvendelse af blod, som har en foröget koncentration af nitrogenoxid, til fremstilling af et medikament

Country Status (13)

Country Link
US (1) US5834030A (pt)
EP (2) EP0680346B1 (pt)
JP (1) JP3989949B2 (pt)
AT (2) ATE350046T1 (pt)
AU (1) AU681999B2 (pt)
CA (1) CA2129630C (pt)
DE (2) DE69334101T2 (pt)
DK (2) DK1243278T3 (pt)
ES (2) ES2280454T3 (pt)
HK (1) HK1053068B (pt)
NZ (1) NZ249176A (pt)
PT (2) PT680346E (pt)
WO (1) WO1993015779A1 (pt)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696092B2 (en) 1992-02-07 2004-02-24 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US5910316A (en) 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
AU760465B2 (en) * 1995-05-05 2003-05-15 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
DK0768886T3 (da) * 1995-05-05 2003-12-01 Vasogen Ireland Ltd Endothelforingseffekter og behandling af vasospastiske lidelser
US6866755B2 (en) * 2001-08-01 2005-03-15 Battelle Memorial Institute Photolytic artificial lung
CA2206180A1 (en) * 1997-05-27 1998-11-27 Vasogen Inc. Treatment of chronic post-traumatic pain syndromes
US6087087A (en) * 1997-07-03 2000-07-11 Takashi Yonetani Treatment of hemoglobin with nitric oxide
WO1999013890A1 (en) * 1997-09-12 1999-03-25 Vasogen Ireland Limited Treatment of stress and preconditioning against stress
JPH11217330A (ja) 1998-01-30 1999-08-10 Sumitomo Pharmaceut Co Ltd 神経栄養因子分泌促進剤
US6264646B1 (en) 1998-11-13 2001-07-24 Vasogen Ireland Limited Method for preventing and reversing atherosclerosis in mammals
JP2002534473A (ja) * 1999-01-12 2002-10-15 パヴェル ハメット， 細胞死に対する予備条件付け
US7045124B1 (en) * 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
US6589759B1 (en) 1999-03-30 2003-07-08 Trustees Of Boston University Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
JP4258908B2 (ja) * 1999-09-14 2009-04-30 株式会社ジェイ・エム・エス 人工肺装置
JP2003509124A (ja) 1999-09-16 2003-03-11 バソジェン アイルランド リミテッド 哺乳動物血液を調整するための装置およびプロセス
US7516742B2 (en) 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
CA2309424A1 (en) * 2000-05-25 2001-11-25 Vasogen Ireland Limited Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
CN1267212C (zh) * 2000-08-11 2006-08-02 大卫·R·怀特洛克 氨氧化细菌在药物中的应用、由其制成的制剂及用其处理过的用品
NL1015999C2 (nl) * 2000-08-23 2002-02-26 A J Van Liebergen Holding B V Inrichting voor het verwarmen van bloed of andere fysiologische vloeistoffen.
CA2327630A1 (en) * 2000-12-05 2002-06-05 Vasogen Ireland Limited Transforming growth factor regulation
US7122018B2 (en) 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7335383B2 (en) * 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
ES2312547T3 (es) * 2001-01-16 2009-03-01 The Regents Of The University Of Michigan Generacion biocatalitica y biomimetica in situ de oxido nitrico en interfases sustrato/sangre.
US7128904B2 (en) * 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US7122208B2 (en) * 2001-04-06 2006-10-17 Vasogen Ireland Limited Compositions containing apoptotic entities
AU2002332450A1 (en) * 2001-08-01 2003-02-17 Eric C. Burckle Artificial pulmonary capillary
US6472390B1 (en) * 2001-11-13 2002-10-29 Duke University Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
WO2003057380A2 (en) * 2002-01-11 2003-07-17 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
CA2377442A1 (en) * 2002-03-20 2003-09-20 Thomas Ichim Increasing tumor oxygen content by administration of stressed cells
MXPA04009897A (es) * 2002-04-10 2004-12-07 Vasogen Ireland Ltd Aspectos electrocardiograficos del tratamiento de la insuficiencia cardiaca congestiva (chf).
US7531133B2 (en) 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
US20050087498A1 (en) * 2003-07-31 2005-04-28 Keyser Steven A. Ozone delivery system including gas-fluid contacting devices and methods of use
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
AU2004275868A1 (en) * 2003-09-26 2005-04-07 David R. Whitlock Methods of using ammonia oxidizing bacteria
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
US8518457B2 (en) 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
JP2007537267A (ja) 2004-05-11 2007-12-20 センサーメディックス・コーポレイション 一酸化窒素ガスの間欠的投与
CA2574228A1 (en) * 2004-07-20 2006-01-26 Vasogen Ireland Limited Acute inflammatory condition treatment
CN100420490C (zh) * 2005-04-13 2008-09-24 刘余厚 全自动紫外线照射充氧自血回输处理方法及设备
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
CA2632224A1 (en) * 2005-12-02 2007-06-07 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same
US8079998B2 (en) 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
US20080181832A1 (en) * 2007-01-30 2008-07-31 Lih-Ren Shiue Pocket-size ozone generator
JP2016517395A (ja) * 2013-02-28 2016-06-16 ニュー・ヘルス・サイエンシーズ・インコーポレイテッドＮｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 血液処理のためのガス枯渇化およびガス添加デバイス
ITMI20131667A1 (it) * 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini Metodo per pre-trattare le cellule ematiche prima della separazione.
KR20210100224A (ko) 2014-04-15 2021-08-13 에이오바이오미 엘엘씨 암모니아-산화 니트로소모나스 유트로파 균주 d23
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
MA39958B1 (fr) * 2014-05-09 2018-10-31 Thankstem S R L Procédé d'expansion de cellules souches adultes à partir de sang total
SE541036C2 (en) 2014-09-15 2019-03-12 Sangair Ab Apparatus and system for ozonating blood, and method for ozonating blood prior to storage
EP4295872A1 (en) * 2022-06-22 2023-12-27 Purotech S.r.l. Blood treatment apparatus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US695647A (en) * 1901-10-30 1902-03-18 James Harold Warner Combination-tile for floors.
DE1068428C2 (de) * 1957-05-21 1960-04-21 Hermann Dr Med Jentjens Verfahren und Einrichtung zur Herstellung von oxygeniertrm Blut
US3325641A (en) * 1964-02-17 1967-06-13 George W Jones Apparatus for treating a thin film of liquid by exposure to radiant energy
US3715430A (en) * 1969-08-04 1973-02-06 E Ryan Purified oxygen gas containing ozone and higher oxygen polymers
DE2926523A1 (de) * 1979-06-30 1981-01-22 Margit Stadtlaender Geraet zur therapeutischen behandlung von blut und anderen koerpereigenen wie auch koerperfremden fluessigkeiten, substanzen und gasen zum zweck der therapeutischen wie auch diagnostischen anwendung in der human- wie auch veterinaermedinzin usw.
JPS58198466A (ja) * 1982-05-12 1983-11-18 Teijin Ltd ５−チアプロスタグランジン類およびその製造法
DD249143A3 (de) * 1985-03-20 1987-09-02 Ilmenau Tech Hochschule Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE8704467U1 (de) * 1987-01-15 1988-05-26 Quarzlampenfabrik Dr.-Ing. Felix W. Müller GmbH & Co KG, 45239 Essen Gerät zur Herstellung von oxygeniertem Blut
JPH01207070A (ja) * 1987-10-22 1989-08-21 Jr Robert E Duthie 滅菌方法および装置
EP0339924B1 (en) * 1988-04-29 1995-03-29 Medizone International, Inc. Apparatus for the controlled generation and administration of ozone
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human

Also Published As

Publication number Publication date
ATE350046T1 (de) 2007-01-15
ATE219953T1 (de) 2002-07-15
DE69334101T2 (de) 2007-10-04
DK1243278T3 (da) 2007-05-07
HK1053068B (zh) 2007-03-30
EP1243278B1 (en) 2007-01-03
EP0680346B1 (en) 2002-07-03
EP0680346A1 (en) 1995-11-08
JPH07503722A (ja) 1995-04-20
WO1993015779A1 (en) 1993-08-19
JP3989949B2 (ja) 2007-10-10
EP1243278A2 (en) 2002-09-25
HK1053068A1 (en) 2003-10-10
AU681999B2 (en) 1997-09-18
EP1243278A3 (en) 2003-02-26
CA2129630A1 (en) 1993-08-08
US5834030A (en) 1998-11-10
ES2179828T3 (es) 2003-02-01
PT1243278E (pt) 2007-04-30
PT680346E (pt) 2002-10-31
CA2129630C (en) 2003-09-23
DE69332087T2 (de) 2002-10-24
AU3506393A (en) 1993-09-03
NZ249176A (en) 1996-11-26
DE69334101D1 (de) 2007-02-15
ES2280454T3 (es) 2007-09-16
DE69332087D1 (de) 2002-08-08

Similar Documents

Publication Publication Date Title
DK0680346T3 (da) Fremgangsmåde til forøgelse af koncentrationen af nitrogenoxid i blod
DE10299002I1 (de) Verwendung von No zur Behandlung oder Praevention der Bronchokonstriktion
DE69102695D1 (de) Behandlung von verunreinigten abwässern und bodenwässern.
DK0800407T3 (da) Fremgangsmåde og apparat til behandling af fluider
DK0387867T3 (da) Præparat indeholdende D-cycloserin og D-alanin til forbedring af hukommelse og indlæringsevne eller til behandling af en kognitiv eller psykotisk lidelse
NO20005800L (no) Fremgangsmåte og apparat for inaktivering av forurensninger i biologisk fluid
DE3584027D1 (de) Verwendung von chlordioxidgas als chemisches sterilisierungsmittel.
BR9104988A (pt) Processo de determinacao da concentracao de um agente de tratamento adicionado a um corpo circulacao de agua,e,processo de determinacao do consumo de um agente de tratamento
SE8802781D0 (sv) Forfarande for avfuktning av gaser
DK0583925T3 (da) Rapamycin til behandling af Crohn's sygdom, ulcerøs colitis og ulcerøs proctitis
NO944456L (no) Behandling av inkontinens
DE59103000D1 (de) Anordnung zur Gasbehandlung von verunreinigtem Erdreich.
DE69432279D1 (de) Methode und Katalysator zur Behandlung von Dioxinen enthaltenden Rauchgasen
SE9302478D0 (sv) Gasblandning och apparat foer att tillfoera gasblandningen till lungorna hos ett levande vaesen
MX9401175A (es) Inhibidores de la acetilcolinesterasa sililada.
DE69308879D1 (de) Methode zur behandlung von abfallverbrennungsrückständen und deren verwendung als adsorptionsmittel
DK0655243T3 (da) Melatoninderivater til anvendelse ved behandling af søvnlidelser
FI962549A (fi) Metallinen siirrännäinen ja menetelmä metallisen siirrännäisen käsittelemiseksi
DE69507518D1 (de) Verfahren zur Behandlung von Schwefeldioxid enthaltenden Gasen
FR2713511B1 (fr) Procédé et dispositif de création d'une atmosphère d'espèces gazeuses excitées ou instables.
DE58900998D1 (de) Verfahren zur entgiftung eines durch chromat belasteten bodens.
SE9301606D0 (sv) Composition for the treatment of impaired hair growth
BR9103795A (pt) Processo de tratamento de liquidos,gases e vapores de cemiterios com unidades de sepultamento estanque
JPS51119672A (en) Denitrating method
FR2691375B1 (fr) Procédé de traitement de gaz malodorants et/ou toxiques.